TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial.

Jennifer Hammond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.